{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T05:16:37Z","timestamp":1781327797859,"version":"3.54.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T00:00:00Z","timestamp":1547683200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["MDA 238981"],"award-info":[{"award-number":["MDA 238981"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["GM103440"],"award-info":[{"award-number":["GM103440"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["8 P20 GM103440-11"],"award-info":[{"award-number":["8 P20 GM103440-11"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.omtm.2019.01.004","type":"journal-article","created":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T10:41:10Z","timestamp":1548153670000},"page":"145-153","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Human Galectin-1 Improves Sarcolemma Stability and Muscle Vascularization in the mdx Mouse Model of Duchenne Muscular Dystrophy"],"prefix":"10.1016","volume":"13","author":[{"given":"Ryan D.","family":"Wuebbles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pam","family":"Van Ry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Barraza-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Brewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean J.","family":"Burkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2019.01.004_bib1","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1212\/WNL.0000000000002891","article-title":"DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study","volume":"87","author":"Bello","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.omtm.2019.01.004_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1146\/annurev-genom-090314-025003","article-title":"The Pathogenesis and Therapy of Muscular Dystrophies","volume":"16","author":"Guiraud","year":"2015","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"key":"10.1016\/j.omtm.2019.01.004_bib3","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1002\/mus.880170405","article-title":"Deflazacort in Duchenne dystrophy: study of long-term effect","volume":"17","author":"Angelini","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2019.01.004_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/archneur.62.1.128","article-title":"Intermittent prednisone therapy in Duchenne muscular dystrophy: a randomized controlled trial","volume":"62","author":"Beenakker","year":"2005","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.omtm.2019.01.004_bib5","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1212\/WNL.41.12.1874","article-title":"Long-term benefit from prednisone therapy in Duchenne muscular dystrophy","volume":"41","author":"Fenichel","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.omtm.2019.01.004_bib6","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1001\/archneur.1991.00530180027012","article-title":"A comparison of daily and alternate-day prednisone therapy in the treatment of Duchenne muscular dystrophy","volume":"48","author":"Fenichel","year":"1991","journal-title":"Arch. Neurol."},{"issue":"Suppl","key":"10.1016\/j.omtm.2019.01.004_bib7","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/0387-7604(95)00015-1","article-title":"Deflazacort vs. prednisone in Duchenne muscular dystrophy: trends of an ongoing study","volume":"17","author":"Reitter","year":"1995","journal-title":"Brain Dev."},{"key":"10.1016\/j.omtm.2019.01.004_bib8","first-page":"1175","article-title":"Levels of \u03b17 integrin and laminin-\u03b12 are increased following prednisone treatment in the mdx mouse and GRMD dog models of Duchenne muscular dystrophy","volume":"6","author":"Wuebbles","year":"2013","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.omtm.2019.01.004_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1517\/14728214.2012.691965","article-title":"Emerging drugs for Duchenne muscular dystrophy","volume":"17","author":"Malik","year":"2012","journal-title":"Expert Opin. Emerg. Drugs"},{"key":"10.1016\/j.omtm.2019.01.004_bib10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1080\/21678707.2016.1240613","article-title":"Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophy","volume":"4","author":"Spinazzola","year":"2016","journal-title":"Expert Opin. Orphan Drugs"},{"key":"10.1016\/j.omtm.2019.01.004_bib11","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1038\/mt.2015.105","article-title":"Galectin-1 Protein Therapy Prevents Pathology and Improves Muscle Function in the mdx Mouse Model of Duchenne Muscular Dystrophy","volume":"23","author":"Van Ry","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2019.01.004_bib12","doi-asserted-by":"crossref","first-page":"137R","DOI":"10.1093\/glycob\/cwl025","article-title":"Galectin-1: a small protein with major functions","volume":"16","author":"Camby","year":"2006","journal-title":"Glycobiology"},{"key":"10.1016\/j.omtm.2019.01.004_bib13","doi-asserted-by":"crossref","first-page":"e65831","DOI":"10.1371\/journal.pone.0065831","article-title":"Isobaric Tagging-Based Quantification for Proteomic Analysis: A Comparative Study of Spared and Affected Muscles from mdx Mice at the Early Phase of Dystrophy","volume":"8","author":"Matsumura","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2019.01.004_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/humupd\/dmt040","article-title":"Involvement of galectin-1 in reproduction: past, present and future","volume":"20","author":"Barrientos","year":"2014","journal-title":"Hum. Reprod. Update"},{"key":"10.1016\/j.omtm.2019.01.004_bib15","doi-asserted-by":"crossref","first-page":"E344","DOI":"10.3390\/genes8120344","article-title":"Alternative Splicing of L-type CaV1.2 Calcium Channels: Implications in Cardiovascular Diseases","volume":"8","author":"Hu","year":"2017","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.omtm.2019.01.004_bib16","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1161\/CIRCRESAHA.111.248849","article-title":"Splice variant specific modulation of CaV1.2 calcium channel by galectin-1 regulates arterial constriction","volume":"109","author":"Wang","year":"2011","journal-title":"Circ. Res."},{"key":"10.1016\/j.omtm.2019.01.004_bib17","doi-asserted-by":"crossref","first-page":"9805","DOI":"10.1073\/pnas.0803223105","article-title":"Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1","volume":"105","author":"Cha","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2019.01.004_bib18","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1634\/stemcells.2005-0564","article-title":"Galectin-1 induces skeletal muscle differentiation in human fetal mesenchymal stem cells and increases muscle regeneration","volume":"24","author":"Chan","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.omtm.2019.01.004_bib19","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1002\/dvdy.21123","article-title":"Lack of galectin-1 results in defects in myoblast fusion and muscle regeneration","volume":"236","author":"Georgiadis","year":"2007","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.omtm.2019.01.004_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1242\/jcs.107.1.175","article-title":"Selective modulation of the interaction of alpha 7 beta 1 integrin with fibronectin and laminin by L-14 lectin during skeletal muscle differentiation","volume":"107","author":"Gu","year":"1994","journal-title":"J.\u00a0Cell Sci."},{"key":"10.1016\/j.omtm.2019.01.004_bib21","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2174\/1389450054021918","article-title":"Galectin-1 is a novel factor that regulates myotube growth in regenerating skeletal muscles","volume":"6","author":"Kami","year":"2005","journal-title":"Curr. Drug Targets"},{"key":"10.1016\/j.omtm.2019.01.004_bib22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1023\/B:GLYC.0000014093.23509.92","article-title":"The involvement of galectin-1 in skeletal muscle determination, differentiation and regeneration","volume":"19","author":"Watt","year":"2002","journal-title":"Glycoconj. J."},{"key":"10.1016\/j.omtm.2019.01.004_bib23","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.bbrc.2003.09.112","article-title":"Galectin-1 interacts with beta-1 subunit of integrin","volume":"310","author":"Moiseeva","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.omtm.2019.01.004_bib24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1093\/glycob\/cwu048","article-title":"Galectin-1 and -9 in angiogenesis: a sweet couple","volume":"24","author":"Thijssen","year":"2014","journal-title":"Glycobiology"},{"key":"10.1016\/j.omtm.2019.01.004_bib25","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/ijc.30131","article-title":"A key role for galectin-1 in sprouting angiogenesis revealed by novel rationally designed antibodies","volume":"139","author":"van Beijnum","year":"2016","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.omtm.2019.01.004_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.expneurol.2005.02.011","article-title":"Neuroprotective effect of oxidized galectin-1 in a transgenic mouse model of amyotrophic lateral sclerosis","volume":"194","author":"Chang-Hong","year":"2005","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.omtm.2019.01.004_bib27","doi-asserted-by":"crossref","first-page":"9964","DOI":"10.1523\/JNEUROSCI.19-22-09964.1999","article-title":"Galectin-1 regulates initial axonal growth in peripheral nerves after axotomy","volume":"19","author":"Horie","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.omtm.2019.01.004_bib28","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.molimm.2011.05.021","article-title":"Nuclear factor (NF)-\u03baB controls expression of the immunoregulatory glycan-binding protein galectin-1","volume":"48","author":"Toscano","year":"2011","journal-title":"Mol. Immunol."},{"key":"10.1016\/j.omtm.2019.01.004_bib29","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1007\/s10555-012-9388-2","article-title":"Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment","volume":"31","author":"Ito","year":"2012","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.omtm.2019.01.004_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0378-4347(97)00336-8","article-title":"Affinity purification and characterization of recombinant human galectin-1","volume":"706","author":"Fouillit","year":"1998","journal-title":"J.\u00a0Chromatogr. B Biomed. Sci. Appl."},{"key":"10.1016\/j.omtm.2019.01.004_bib31","doi-asserted-by":"crossref","first-page":"3737","DOI":"10.1096\/fj.07-8459com","article-title":"VEGF overexpression via adeno-associated virus gene transfer promotes skeletal muscle regeneration and enhances muscle function in mdx mice","volume":"21","author":"Messina","year":"2007","journal-title":"FASEB J."},{"key":"10.1016\/j.omtm.2019.01.004_bib32","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/mus.880040511","article-title":"In\u00a0vivo morphometric analysis of muscle microcirculation in dystrophic mice","volume":"4","author":"Burch","year":"1981","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.omtm.2019.01.004_bib33","first-page":"2955","article-title":"Oxidized galectin-1 promotes axonal regeneration in peripheral nerves but does not possess lectin properties","volume":"267","author":"Inagaki","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.omtm.2019.01.004_bib34","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1096\/fj.07-9524com","article-title":"The immunoregulatory glycan-binding protein galectin-1 triggers human platelet activation","volume":"22","author":"Pacienza","year":"2008","journal-title":"FASEB J."},{"key":"10.1016\/j.omtm.2019.01.004_bib35","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1093\/glycob\/cwu008","article-title":"Structural basis of redox-dependent modulation of galectin-1 dynamics and function","volume":"24","author":"Guardia","year":"2014","journal-title":"Glycobiology"},{"key":"10.1016\/j.omtm.2019.01.004_bib36","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.clim.2011.09.011","article-title":"Galectin-1 research in T\u00a0cell immunity: past, present and future","volume":"142","author":"Cedeno-Laurent","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.omtm.2019.01.004_bib37","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.biochi.2015.06.013","article-title":"Redox state influence on human galectin-1 function","volume":"116","author":"Yu","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.omtm.2019.01.004_bib38","doi-asserted-by":"crossref","first-page":"13818","DOI":"10.1073\/pnas.250379497","article-title":"Functional muscle ischemia in neuronal nitric oxide synthase-deficient skeletal muscle of children with Duchenne muscular dystrophy","volume":"97","author":"Sander","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2019.01.004_bib39","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.cell.2014.01.059","article-title":"Galectin-1 Pulls the Strings on VEGFR2","volume":"156","author":"Stanley","year":"2014","journal-title":"Cell"},{"key":"10.1016\/j.omtm.2019.01.004_bib40","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.nmd.2004.11.002","article-title":"Microvessel density in muscles of dogs with golden retriever muscular dystrophy","volume":"15","author":"Nguyen","year":"2005","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.omtm.2019.01.004_bib41","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1161\/ATVBAHA.112.301172","article-title":"Angiogenic impairment of the vascular endothelium: a novel mechanism and potential therapeutic target in muscular dystrophy","volume":"33","author":"Palladino","year":"2013","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.omtm.2019.01.004_bib42","doi-asserted-by":"crossref","first-page":"e806","DOI":"10.1371\/journal.pone.0000806","article-title":"Primary role of functional ischemia, quantitative evidence for the two-hit mechanism, and phosphodiesterase-5 inhibitor therapy in mouse muscular dystrophy","volume":"2","author":"Asai","year":"2007","journal-title":"PLoS ONE"},{"key":"10.1016\/j.omtm.2019.01.004_bib43","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ymthe.2017.03.022","article-title":"SU9516 Increases \u03b17\u03b21 Integrin and Ameliorates Disease Progression in the mdx Mouse Model of Duchenne Muscular Dystrophy","volume":"25","author":"Sarathy","year":"2017","journal-title":"Mol. Ther."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119300075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050119300075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T09:23:58Z","timestamp":1762421038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050119300075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":43,"alternative-id":["S2329050119300075"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2019.01.004","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human Galectin-1 Improves Sarcolemma Stability and Muscle Vascularization in the mdx Mouse Model of Duchenne Muscular Dystrophy","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2019.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s).","name":"copyright","label":"Copyright"}]}}